IMUX News and Press, Immunic Inc. From 05/08/24

2024-05-08 14:20:08 ET Immunic, Inc. (IMUX) Q1 2024 Earnings Conference Call May 08, 2024 08:00 AM ET Company Participants Jessica Breu - Vice President, Investor Relations & Communications Daniel Vitt - Chief Executive Officer, President & Director Glenn...

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

2024-05-08 06:34:45 ET More on Immunic Immunic, Inc. (IMUX) Q4 2023 Earnings Call Transcript Brookline Capital starts Immunic at buy, cites MS drug candidate Seeking Alpha’s Quant Rating on Immunic Historical earnings data for Immunic Financial...

Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire – Substantially Bolstered Balance Sheet Through a Three-Tranche Private Placement Totaling Up to $240 Million , Extending Cash Runway Into the Third Quarter of 2025,...

2024-05-07 14:13:32 ET More on Immunic Immunic, Inc. (IMUX) Q4 2023 Earnings Call Transcript Brookline Capital starts Immunic at buy, cites MS drug candidate Seeking Alpha’s Quant Rating on Immunic Historical earnings data for Immunic Financial...

2024-05-07 11:00:00 ET Major earnings expected before the bell on Wednesday include: Brookfield Asset Management ( BAM ) Emerson Electric ( EMR ) Shopify ( SHOP ) Teva Pharmaceutical Industries ( TEVA ) Uber Technologies ( UBER ) Read the fu...

--News Direct-- Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the publication of extended data from the Phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting multiple sclerosis (RRMS) in the peer-reviewed journal, Neurology&#x...

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update PR Newswire – Webcast to be Held at 8:00 am ET on May 8, 2024 – NEW YORK , May 1, 2024 /PRNewswire/ -- Immunic, ...

Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation Immunic Announces Publication of Extended Data From Phase 2 ...

--News Direct-- Immunic Inc CEO Dr Daniel Vitt joins Proactive's Stephen Gunnion on the International Day of Immunology to discuss the broad and crucial role of immunology in human health. Vitt said immunology encompasses immune responses against pathogens like viruses, including the ...